Annual Report 2023

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2023 135 The United Laboratories International Holdings Limited Annual Report 2023 39. FINANCIAL INSTRUMENTS (Continued) Financial risk management objectives and policies (Continued) Credit risk and impairment assessment (Continued) External Internal Gross credit credit 12m or carrying 2022 Notes rating rating lifetime ECL amount RMB’000 Pledged bank deposits 25 Aa2 to Baa2 N/A 12m ECL 694,704 Bank balances 25 Aa2 to Caa1 N/A 12m ECL 4,742,721 Other receivables and refundable deposits 24 N/A Note 1 12m ECL 91,970 Consideration receivables 24 N/A Note 4 Lifetime ECL (credit- impaired) 339,574 Banker’s acceptance bills receivables 24 A1 to Caa2 N/A 12m ECL 2,360,224 Commercial bills receivables 24 N/A Note 3 12m ECL 18,909 Trade receivables 24 N/A Note 2 Lifetime ECL (provision matrix) 2,110,751